Sunday, March 13, 2005

Association of CRESTOR (rosuvastatin) with muscle related adverse events

From Health Canada:
AstraZeneca Canada Inc., in consultation with Health Canada, would like to inform patients of important safety information for CRESTOR® (rosuvastatin) tablets.

CRESTOR® is a cholesterol-lowering drug in the "statin" family. Statins are a specific type of medication used to lower cholesterol.

In Canada, and internationally, CRESTOR® has been associated with rare reports of a serious condition called rhabdomyolysis. Rhabdomyolysis is a condition that results in muscle breakdown and release of muscle cell contents into the bloodstream. In severe cases, rhabdomyolysis can lead to kidney failure and be life-threatening. Some patients may have pre-existing medical conditions which might cause them to have a greater risk of developing muscle related problems, including rhabdomyolysis, if they are using "statin" medications. ...more

No comments: